London’s FDI Offers Help To Mid-Size Indian Drug Makers, Biotechs
This article was originally published in PharmAsia News
Executive Summary
London's foreign direct investment agency is looking at medium-size drug makers as possible targets for assisting in expanding their plans in Europe. Think London already is in negotiations with five unidentified Indian firms, offering help with agreements between them and 100 London-based drug makers and biotechs. The union is designed to help the Indian firms get market access to local regulatory agencies in Europe. Past clients in India include Arch Pharma, Aurobindo Pharma and Intas Pharmaceutical. (Click here for more